<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Anti-<z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> A-1 (Apo A-1) autoantibodies were described in <z:hpo ids='HP_0002960'>autoimmune disorders</z:hpo> such as <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) and <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) and might be involved in the genesis of arterial and venous thrombotic events </plain></SENT>
<SENT sid="1" pm="."><plain>To investigate the presence of these autoantibodies in patients with <z:hpo ids='HP_0011009'>acute</z:hpo> coronary syndrome (ACS) without other features of <z:hpo ids='HP_0002960'>autoimmunity</z:hpo>, we set up an enzyme-linked immunosorbent assay (ELISA) for anti-Apo A-1 antibodies </plain></SENT>
<SENT sid="2" pm="."><plain>We used it to investigate their prevalence in ACS as compared to SLE and APS and correlated them to plasma Apo A-1 and serum amyloid A protein (SAA) concentrations </plain></SENT>
<SENT sid="3" pm="."><plain>The prevalence of anti-Apo A-1 autoantibodies in the healthy control group was 1% (1/92), but was significantly higher in other groups: 21% (11/53) in ACS group (P=0.001), 13% (12/92) in SLE and/or APS group (P=0.005) </plain></SENT>
<SENT sid="4" pm="."><plain>Multiple linear regression revealed a significant correlation between plasma Apo A-1 (r=-0.72, P=0.013), plasma SAA concentration (r=0.76, P=0.0066) and anti-Apo A-1 IgG titre in ACS patients </plain></SENT>
<SENT sid="5" pm="."><plain>The presence of anti-Apo A-1 autoantibodies in patients with ACS highlights an additional link between <z:hpo ids='HP_0002960'>autoimmunity</z:hpo>, <z:mp ids='MP_0001845'>inflammation</z:mp> and <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> </plain></SENT>
</text></document>